10-30327945-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_018109.4(MTPAP):c.781-1310A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.404 in 152,034 control chromosomes in the GnomAD database, including 15,348 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 15348 hom., cov: 32)
Consequence
MTPAP
NM_018109.4 intron
NM_018109.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.142
Publications
7 publications found
Genes affected
MTPAP (HGNC:25532): (mitochondrial poly(A) polymerase) The protein encoded by this gene is a member of the DNA polymerase type-B-like family. This enzyme synthesizes the 3' poly(A) tail of mitochondrial transcripts and plays a role in replication-dependent histone mRNA degradation.[provided by RefSeq, Jan 2011]
MTPAP Gene-Disease associations (from GenCC):
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- spastic ataxia 4Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.547 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MTPAP | ENST00000263063.9 | c.781-1310A>G | intron_variant | Intron 4 of 8 | 1 | NM_018109.4 | ENSP00000263063.3 | |||
| MTPAP | ENST00000417581.1 | c.586-1310A>G | intron_variant | Intron 4 of 4 | 5 | ENSP00000404392.1 | ||||
| MTPAP | ENST00000488290.5 | n.2536-1310A>G | intron_variant | Intron 12 of 16 | 2 |
Frequencies
GnomAD3 genomes AF: 0.404 AC: 61356AN: 151920Hom.: 15345 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
61356
AN:
151920
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.404 AC: 61355AN: 152034Hom.: 15348 Cov.: 32 AF XY: 0.402 AC XY: 29897AN XY: 74286 show subpopulations
GnomAD4 genome
AF:
AC:
61355
AN:
152034
Hom.:
Cov.:
32
AF XY:
AC XY:
29897
AN XY:
74286
show subpopulations
African (AFR)
AF:
AC:
4656
AN:
41510
American (AMR)
AF:
AC:
7980
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
1839
AN:
3464
East Asian (EAS)
AF:
AC:
696
AN:
5178
South Asian (SAS)
AF:
AC:
2044
AN:
4820
European-Finnish (FIN)
AF:
AC:
5144
AN:
10532
Middle Eastern (MID)
AF:
AC:
166
AN:
292
European-Non Finnish (NFE)
AF:
AC:
37485
AN:
67952
Other (OTH)
AF:
AC:
935
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1573
3146
4718
6291
7864
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
564
1128
1692
2256
2820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
962
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.